<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "JATS-journalpublishing1.dtd">
<article xml:lang="KO" article-type="research-article">

<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Korean Ophthalmol Soc</journal-id>
<journal-id journal-id-type="publisher-id">JKOS</journal-id>
<journal-title-group>
<journal-title>Journal of the Korean Ophthalmological Society</journal-title>
</journal-title-group>
<issn pub-type="ppub">0378-6471</issn>
<issn pub-type="epub">2092-9374</issn>
<publisher>
<publisher-name>The Korean Ophthalmological Society</publisher-name>
</publisher>
</journal-meta>

<article-meta>
<article-id pub-id-type="doi">10.3341/jkos.2017.58.4.415</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Prognostic Factors of Neovascular Glaucoma in Eyes with Treated Proliferative Diabetic Retinopathy</article-title>
</title-group>

<contrib-group>

<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Ji Hyun</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1"></xref>
</contrib>

<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Eun Yeong</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1"></xref>
</contrib>

<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Tai Kyong</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1"></xref>
</contrib>

<contrib contrib-type="author">
<name>
<surname>Shin</surname>
<given-names>Hye Young</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1"></xref>
</contrib>

<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Su Young</given-names>
</name>
<degrees>MD</degrees>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1"></xref>
</contrib>

<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Young Chun</given-names>
</name>
<degrees>MD</degrees>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1"></xref>
</contrib>

<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lee</surname>
<given-names>Mee Yon</given-names>
</name>
<degrees>MD</degrees>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1"></xref>
</contrib>

</contrib-group>

<aff id="A1">Department of Ophthalmology and Visual Science, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea.</aff>

<author-notes>
<corresp>Address reprint requests to Mee Yon Lee, MD, PhD. Department of Ophthalmology, The Catholic University of Korea Uijeongbu St. Mary's Hospital, #271 Cheonbo-ro, Uijeongbu 11765, Korea. Tel: 82-31-820-3022, Fax: 82-31-847-3418, <email>deenie@daum.net</email></corresp>
</author-notes>

<pub-date pub-type="ppub">
<month>04</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>14</day>
<month>04</month>
<year>2017</year>
</pub-date>
<volume>58</volume>
<issue>4</issue>
<fpage>415</fpage>
<lpage>419</lpage>

<history>
<date date-type="received">
<day>08</day>
<month>12</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>15</day>
<month>02</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>03</month>
<year>2017</year>
</date>
</history>

<permissions>
<copyright-statement>&#x00A9;2017 The Korean Ophthalmological Society</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>

<abstract>
<sec>
<title>Purpose</title>
<p>To evaluate the factors that are significant in progression to neovascular glaucoma in patients with proliferative diabetic retinopathy.</p>
</sec>
<sec>
<title>Methods</title>
<p>In this retrospective analysis, we reviewed the medical records of 52 patients who were first diagnosed with proliferative diabetic retinopathy from March 2014 to March 2016. We compared diabetes mellitus period, HbA1c, chronic diseases such as hypertension, hyperlipidemia, and kidney disease, insulin treatments, blood urea nitrogen, blood creatinine, glomerular filtration rate, urine albumin, dialysis, corrected visual acuity at the first visit, traction membrane sign of the retina at the first visit, vitreous hemorrhage and preretinal hemorrhage in each group and then investigated the prognostic factors of neovascular glaucoma.</p>
</sec>
<sec>
<title>Results</title>
<p>A total of 52 patients were included in the investigation, 12 patients (23.08%) were diagnosed with iris neovascularization and 4 patients (7.69%) developed neovascular glaucoma. The patients without iris neovascularization were defined as Group I, those with iris neovascularization as Group II, and those with neovascular glaucoma as Group III. The diabetes mellitus period was significantly longer in Group II (10.88 &#x00B1; 7.14 years) and in Group III (11.75 &#x00B1; 8.61 years) than Group I (8.30 &#x00B1; 5.25 years) (<italic>p</italic>-value 0.41, 0.032, respectively). The HbA1c level was 9.59 &#x00B1; 2.23 in Group II and 9.27 &#x00B1; 2.54 in Group I. There was no significant difference between the two groups (<italic>p</italic> = 0.721). However, HbA1c was significantly higher in Group III (11.55 &#x00B1; 0.21) than Group I (<italic>p</italic>-value 0.048).</p>
</sec>
<sec>
<title>Conclusions</title>
<p>A long diabetes mellitus period and high HbA1c level have a significant effect on the progression to neovascular glaucoma in patients with proliferative diabetic retinopathy. This information could be useful for predicting and preventing the prognosis of patients.</p>
</sec>
</abstract>

<kwd-group>
<kwd>Diabetes mellitus</kwd>
<kwd>Hb1AC</kwd>
<kwd>Neovascular glaucoma</kwd>
<kwd>Proliferative diabetic retinopathy</kwd>
</kwd-group>

</article-meta>
</front>

<back>

    <ref-list>
  <ref id="B1">
    <label>1</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Sivak-Callcott</surname>
          <given-names>JA</given-names>
        </name>
        <name>
          <surname>O'Day</surname>
          <given-names>DM</given-names>
        </name>
        <name>
          <surname>Gass</surname>
          <given-names>JD</given-names>
        </name>
        <name>
          <surname>Tsai</surname>
          <given-names>JC</given-names>
        </name>
      </person-group>
      <article-title>Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma</article-title>
      <source>Ophthalmology</source>
      <year>2001</year>
      <volume>108</volume>
      <fpage>1767</fpage>
      <lpage>1776</lpage>
      <comment>quiz 1777, 1800</comment>
    </element-citation>
  </ref>

  <ref id="B2">
    <label>2</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Ohrt</surname>
          <given-names>V</given-names>
        </name>
      </person-group>
      <article-title>The frequency of rubeosis iridis in diabetic patients</article-title>
      <source>Acta Ophthalmol (Copenh)</source>
      <year>1971</year>
      <volume>49</volume>
      <fpage>301</fpage>
      <lpage>307</lpage>
    </element-citation>
  </ref>

  <ref id="B3">
    <label>3</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Madsen</surname>
          <given-names>PH</given-names>
        </name>
      </person-group>
      <article-title>Rubeosis of the iris and haemorrhagic glaucoma in patients with proliferative diabetic retinopathy</article-title>
      <source>Br J Ophthmol</source>
      <year>1971</year>
      <volume>55</volume>
      <fpage>368</fpage>
      <lpage>371</lpage>
    </element-citation>
  </ref>

  <ref id="B4">
    <label>4</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Shazly</surname>
          <given-names>TA</given-names>
        </name>
        <name>
          <surname>Latina</surname>
          <given-names>MA</given-names>
        </name>
      </person-group>
      <article-title>Neovascular glaucoma: etiology, diagnosis and prognosis</article-title>
      <source>Semin Ophthalmol</source>
      <year>2009</year>
      <volume>24</volume>
      <fpage>113</fpage>
      <lpage>121</lpage>
    </element-citation>
  </ref>

  <ref id="B5">
    <label>5</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Klein</surname>
          <given-names>R</given-names>
        </name>
        <name>
          <surname>Klein</surname>
          <given-names>BE</given-names>
        </name>
        <name>
          <surname>Moss</surname>
          <given-names>SE</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>The Wisconsin Epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema</article-title>
      <source>Ophthalmology</source>
      <year>1984</year>
      <volume>91</volume>
      <fpage>1464</fpage>
      <lpage>1474</lpage>
    </element-citation>
  </ref>

  <ref id="B6">
    <label>6</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Klein</surname>
          <given-names>R</given-names>
        </name>
        <name>
          <surname>Klein</surname>
          <given-names>BE</given-names>
        </name>
        <name>
          <surname>Moss</surname>
          <given-names>SE</given-names>
        </name>
        <name>
          <surname>Cruickshanks</surname>
          <given-names>KJ</given-names>
        </name>
      </person-group>
      <article-title>The Wisconsin epidemiologic study of diabetic retinopathy. XV. The long-term incidence of macular edema</article-title>
      <source>Ophthalmology</source>
      <year>1995</year>
      <volume>102</volume>
      <fpage>7</fpage>
      <lpage>16</lpage>
    </element-citation>
  </ref>

  <ref id="B7">
    <label>7</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Tripathi</surname>
          <given-names>RC</given-names>
        </name>
        <name>
          <surname>Li</surname>
          <given-names>J</given-names>
        </name>
        <name>
          <surname>Tripathi</surname>
          <given-names>BJ</given-names>
        </name>
        <etal/>
      </person-group>
      <article-title>Increased level of vascular endothelial growth factor in queous humor of patients with neovascular glaucoma</article-title>
      <source>Ophthalmology</source>
      <year>1998</year>
      <volume>105</volume>
      <fpage>232</fpage>
      <lpage>237</lpage>
    </element-citation>
  </ref>

  <ref id="B8">
    <label>8</label>
    <element-citation publication-type="journal">
      <person-group person-group-type="author">
        <name>
          <surname>Wand</surname>
          <given-names>M</given-names>
        </name>
        <name>
          <surname>Madigan</surname>
          <given-names>JC</given-names>
        </name>
        <name>
          <surname>Gaudio</surname>
          <given-names>AR</given-names>
        </name>
        <name>
          <surname>Sorokanich</surname>
          <given-names>S</given-names>
        </name>
      </person-group>
      <article-title>Neovascular glaucoma following pars plana vitrectomy for complication of diabetic retinopathy</article-title>
      <source>Ophthalmic Surg</source>
      <year>1990</year>
      <volume>21</volume>
      <fpage>113</fpage>
      <lpage>118</lpage>
    </element-citation>
  </ref>
    </ref-list>

</back>

<floats-group>

<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption>
  <title>Demographics of three groups</title>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jkos-58-415-i001"></graphic>
<table-wrap-foot>
<fn>
  <p>Values are presented as mean &#x00B1; SD unless otherwise indicated. &#x2018;Group I&#x2019; means &#x2018;Control Group&#x2019;, &#x2018;Group II&#x2019; means &#x2018;patients who developed neovascular iridis&#x2019;, and &#x2018;Group III&#x2019; means &#x2018;Patients who developed neovascular glaucoma&#x2019;.</p>
  <p>SD = standard deviation; DM = diabetic mellitus; BUN = blood urea nitrogen; Cr = Creatinine; GFR = glomerular filtration rate.</p>
  <p><sup>*</sup>Statistically significant; <sup>&#x2020;</sup>Comparison between Group I and Group II (Student <italic>t</italic>-test for continuous variables, chai-square test for discontinuous variables); <sup>&#x2021;</sup>Comparison between Group I and Group III (Mann-Whitney <italic>U</italic>-test for continuous variables, chai-square test for discontinuous variables).</p>
</fn>
</table-wrap-foot>
</table-wrap>

<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption>
  <title>Demographics of three groups according to ophthalmologic examination</title>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jkos-58-415-i002"></graphic>
<table-wrap-foot>
<fn>
  <p>Values are presented as mean &#x00B1; SD or n (%) unless otherwise indicated. &#x2018;Group I&#x2019; means &#x2018;Control Group&#x2019;, &#x2018;Group II&#x2019; means &#x2018;Patients who developed neovascular iridis&#x2019; and &#x2018;Group III&#x2019; means &#x2018;Patients who developed neovascular glaucoma&#x2019;.</p>
  <p>SD = standard deviation; BCVA = best corrected visual acuity.</p>
  <p><sup>*</sup>Comparison between Group I and Group II (Student <italic>t</italic>-test for continuous variables, chai-square test for discontinuous variables); <sup>&#x2020;</sup>Comparison between Group I and Group III (Mann-Whitney <italic>U</italic>-test for continuous variables, chai-square test for discontinuous variables).</p>
</fn>
</table-wrap-foot>
</table-wrap>

</floats-group>

</article>